These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 12364477

  • 1. Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors.
    Martins L, Matsuo SE, Ebina KN, Kulcsar MA, Friguglietti CU, Kimura ET.
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4806-10. PubMed ID: 12364477
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Galectin-3 is a presurgical marker of human thyroid carcinoma.
    Orlandi F, Saggiorato E, Pivano G, Puligheddu B, Termine A, Cappia S, De Giuli P, Angeli A.
    Cancer Res; 1998 Jul 15; 58(14):3015-20. PubMed ID: 9679965
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
    Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J, Hattori K, Okamoto S, Sawada T, Raz A, Kubo T.
    Cancer; 1999 Jun 01; 85(11):2475-84. PubMed ID: 10357421
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications.
    Xu XC, el-Naggar AK, Lotan R.
    Am J Pathol; 1995 Sep 01; 147(3):815-22. PubMed ID: 7677193
    [Abstract] [Full Text] [Related]

  • 11. Expression of cytokeratin 20 in thyroid carcinomas and peripheral blood detected by reverse transcription polymerase chain reaction.
    Weber T, Lacroix J, Weitz J, Amnan K, Magener A, Hölting T, Klar E, Herfarth C, von Knebel Doeberitz M.
    Br J Cancer; 2000 Jan 01; 82(1):157-60. PubMed ID: 10638983
    [Abstract] [Full Text] [Related]

  • 12. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.
    Fernández PL, Merino MJ, Gómez M, Campo E, Medina T, Castronovo V, Sanjuán X, Cardesa A, Liu FT, Sobel ME.
    J Pathol; 1997 Jan 01; 181(1):80-6. PubMed ID: 9072007
    [Abstract] [Full Text] [Related]

  • 13. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
    Chiappetta G, Tallini G, De Biasio MC, Manfioletti G, Martinez-Tello FJ, Pentimalli F, de Nigris F, Mastro A, Botti G, Fedele M, Berger N, Santoro M, Giancotti V, Fusco A.
    Cancer Res; 1998 Sep 15; 58(18):4193-8. PubMed ID: 9751634
    [Abstract] [Full Text] [Related]

  • 14. Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry.
    Feilchenfeldt J, Tötsch M, Sheu SY, Robert J, Spiliopoulos A, Frilling A, Schmid KW, Meier CA.
    Mod Pathol; 2003 Nov 15; 16(11):1117-23. PubMed ID: 14614051
    [Abstract] [Full Text] [Related]

  • 15. Intensity and distribution of immunohistochemical expression of galectin-3 in thyroid neoplasms.
    Matesa-Anić D, Moslavac S, Matesa N, Cupić H, Kusić Z.
    Acta Clin Croat; 2012 Jun 15; 51(2):237-41. PubMed ID: 23115948
    [Abstract] [Full Text] [Related]

  • 16. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
    Than TH, Swethadri GK, Wong J, Ahmad T, Jamil D, Maganlal RK, Hamdi MM, Abdullah MS.
    Singapore Med J; 2008 Apr 15; 49(4):333-8. PubMed ID: 18418527
    [Abstract] [Full Text] [Related]

  • 17. Blood group antigens in differentiated thyroid neoplasms.
    González-Cámpora R, García-Sanatana JA, Jordà i Heras MM, Salaverri CO, Vázquez-Ramírez FJ, Argueta-Manzano OE, Galera-Davidson H.
    Arch Pathol Lab Med; 1998 Nov 15; 122(11):957-65. PubMed ID: 9822123
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma.
    Jakubiak-Wielganowicz M, Kubiak R, Sygut J, Pomorski L, Kordek R.
    Pol J Pathol; 2003 Nov 15; 54(2):111-5. PubMed ID: 14575419
    [Abstract] [Full Text] [Related]

  • 19. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
    Nascimento MC, Bisi H, Alves VA, Longatto-Filho A, Kanamura CT, Medeiros-Neto G.
    Endocr Pathol; 2001 Nov 15; 12(3):275-9. PubMed ID: 11740048
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of galectin-3 in papillary projections of malignant and non-malignant hyperplastic thyroid lesions.
    Cvejić D, Savin S, Petrović I, Paunović I, Tatić S, Havelka M.
    Acta Chir Iugosl; 2003 Nov 15; 50(3):67-70. PubMed ID: 15179758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.